Company Filing History:
Years Active: 2025
Title: The Innovations of Constantine Chrysostomou
Introduction
Constantine Chrysostomou is an accomplished inventor based in Fairfax Station, VA (US). He has made significant contributions to the field of biotechnology, particularly in the development of homing endonuclease variants.
Latest Patents
Chrysostomou holds a patent for "Homing endonuclease variants." This patent provides innovative homing endonuclease variants and megaTALs that are reprogrammed to bind and cleave specific polynucleotide sequences in the genome. The engineered variants are designed to enhance thermostability and/or activity, showcasing his commitment to advancing genetic engineering technologies. He has 1 patent to his name.
Career Highlights
Chrysostomou is currently employed at Novo Nordisk A/S, a leading global healthcare company. His work focuses on developing cutting-edge solutions in the field of biotechnology, contributing to the company's mission of improving patient care.
Collaborations
Some of his notable coworkers include Jordan Jarjour and Kyle Havens, who collaborate with him on various projects within the company.
Conclusion
Constantine Chrysostomou's innovative work in biotechnology, particularly with homing endonuclease variants, highlights his role as a key inventor in the field. His contributions continue to pave the way for advancements in genetic engineering and therapeutic solutions.